Specific drugs and genes showed great therapeutic potential for the treatment of different kinds of diseases. Notably, in many cases, drugs and genes need to be delivered to the appropriate organs, tissues, or even specific cells. However, the natural physiological barriers and complex lesion environment in the body make it difficult for drugs and genes to achieve the desired effect. Encouragingly, with the application of nanotechnology and bioengineering strategies, drug and gene delivery systems are developed to overcome physiological barriers and achieve highly efficient cargo delivery based on the unique characteristics of the delivery technologies. The leveraged nanotechnologies and bioengineering platforms for drug and gene delivery bring unexpected new properties, achieve more expansive applications, and promote interdisciplinary collaboration of biologists, material scientists, clinicians, nanotechnologists, and engineering technologists.
This Research Topic aims to:
1. Explore new drug and gene delivery systems utilizing advanced nanotechnology and bioengineering strategies to achieve higher delivery efficacy.
2. Promote the development of nanotechnology and biotechnology-based platforms for precise therapeutics and diagnosis, and improve the transformation of drug and gene delivery systems from basic research to clinical application.
3. Convene interdisciplinary cooperation to promote the development of precision medicine and personalized therapy through nanotechnology and bioengineering strategies from the perspective of disease mechanism exploration at the genetic and molecular level.
The current Research Topic focuses on the latest development of nanotechnology and bioengineering platforms for drug and gene delivery. Preferred themes include but are not limited to:
• Lipid nanoparticles for drug and gene delivery
• Inorganic or organic nanoparticles-based delivery systems
• Nano-engineered or gene-engineered cell-based therapy
• Viral nanoparticle-based delivery systems
• Polymer-based cargo delivery
• Hybrid nanotechnology for drug and gene delivery
• Hydrogel-based delivery systems
• Microneedle-based delivery systems
• Biomimetic nanosystems
• Bioengineering strategies
• Immune-adjuvant, vaccine delivery system, and nanovaccines
• Nanotechnology and biotechnology-based disease diagnosis and therapeutics
• Stimulus-responsive nanomaterials and biomaterials
• Small molecule drugs, antibodies, peptides, siRNA, mRNA, and DNA delivery
• Nano-bio effects and nanotoxicity
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Specific drugs and genes showed great therapeutic potential for the treatment of different kinds of diseases. Notably, in many cases, drugs and genes need to be delivered to the appropriate organs, tissues, or even specific cells. However, the natural physiological barriers and complex lesion environment in the body make it difficult for drugs and genes to achieve the desired effect. Encouragingly, with the application of nanotechnology and bioengineering strategies, drug and gene delivery systems are developed to overcome physiological barriers and achieve highly efficient cargo delivery based on the unique characteristics of the delivery technologies. The leveraged nanotechnologies and bioengineering platforms for drug and gene delivery bring unexpected new properties, achieve more expansive applications, and promote interdisciplinary collaboration of biologists, material scientists, clinicians, nanotechnologists, and engineering technologists.
This Research Topic aims to:
1. Explore new drug and gene delivery systems utilizing advanced nanotechnology and bioengineering strategies to achieve higher delivery efficacy.
2. Promote the development of nanotechnology and biotechnology-based platforms for precise therapeutics and diagnosis, and improve the transformation of drug and gene delivery systems from basic research to clinical application.
3. Convene interdisciplinary cooperation to promote the development of precision medicine and personalized therapy through nanotechnology and bioengineering strategies from the perspective of disease mechanism exploration at the genetic and molecular level.
The current Research Topic focuses on the latest development of nanotechnology and bioengineering platforms for drug and gene delivery. Preferred themes include but are not limited to:
• Lipid nanoparticles for drug and gene delivery
• Inorganic or organic nanoparticles-based delivery systems
• Nano-engineered or gene-engineered cell-based therapy
• Viral nanoparticle-based delivery systems
• Polymer-based cargo delivery
• Hybrid nanotechnology for drug and gene delivery
• Hydrogel-based delivery systems
• Microneedle-based delivery systems
• Biomimetic nanosystems
• Bioengineering strategies
• Immune-adjuvant, vaccine delivery system, and nanovaccines
• Nanotechnology and biotechnology-based disease diagnosis and therapeutics
• Stimulus-responsive nanomaterials and biomaterials
• Small molecule drugs, antibodies, peptides, siRNA, mRNA, and DNA delivery
• Nano-bio effects and nanotoxicity
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
